Previous reports have indicated that the instability of hormone receptors in breast cancer is associated with a poorer prognosis (12, 13), Women whose ER-positive primary tumors transform into ER-negative tumors experience a significant 48% increase in the risk of death (7). This evidence concerns the gene ESR1 and breast cancer.